Endocrinology, Vol 124, 1444-1449, Copyright © 1989 by Endocrine Society

ARTICLES

Effects of protein kinase-C-related adrenocorticotropin secretagogues and interleukin-1 on proopiomelanocortin gene expression in rat anterior pituitary cells

T Suda, F Tozawa, T Ushiyama, N Tomori, T Sumitomo, Y Nakagami, M Yamada, H Demura and K Shizume
Department of Medicine, Tokyo Women's Medical College, Japan.

To examine the effects of the cAMP-independent protein kinase-C system and interleukin-1 (IL-1) on secretion of ACTH and POMC gene expression in cultured rat anterior pituitary (AP) cells, AP cells were incubated with CRF, 8-bromo-cAMP, arginine vasopressin, angiotensin II, norepinephrine, and phorbol 12-myristate 13-acetate. After 15 h of incubation, CRF and 8-bromo-cAMP increased both ACTH release and the POMC mRNA level. Arginine vasopressin, angiotensin II, norepinephrine, or phorbol 12-myristate 13-acetate stimulated ACTH release but failed to increase basal or CRF-stimulated POMC mRNA levels. Human recombinant IL-1 alpha and -beta increased neither ACTH release nor POMC mRNA levels after 3 h of incubation. After 15 h of incubation, 100 pM to 10 nM IL-1 alpha and -beta increased ACTH release. However, POMC mRNA levels were significantly elevated only by 10 pM IL-1 beta. These results suggest that the CRF-cAMP system plays a major role in both ACTH release and expression of the POMC gene in AP cells, but the cAMP- independent protein kinase-C system contributes only to ACTH release; that acute stimulation of ACTH release from AP with IL-1 administration is not due to direct action of IL-1 at the pituitary level; that chronic exposure of AP cells to IL-1 alpha or -beta can stimulate ACTH release; and that the direct effects of IL-1 alpha and -beta on POMC gene expression, if any, seem to be minimal.

This article has been cited by other articles:

				D. Chida, T. Imaki, T. Suda, and Y. Iwakura Involvement of Corticotropin-Releasing Hormone- and Interleukin (IL)-6-Dependent Proopiomelanocortin Induction in the Anterior Pituitary during Hypothalamic-Pituitary-Adrenal Axis Activation by IL-1{alpha} Endocrinology, December 1, 2005; 146(12): 5496 - 5502. [Abstract] [Full Text] [PDF]

				C. Bousquet and S. Melmed Critical Role for STAT3 in Murine Pituitary Adrenocorticotropin Hormone Leukemia Inhibitory Factor Signaling J. Biol. Chem., April 16, 1999; 274(16): 10723 - 10730. [Abstract] [Full Text] [PDF]

				D. W. RAY, S.-G. REN, and S. MELMED Leukemia Inhibitory Factor Regulates Proopiomelanocortin Transcription Ann. N.Y. Acad. Sci., May 1, 1998; 840(1): 162 - 173. [Abstract] [Full Text] [PDF]

				S. Reichlin Editorial: What's In a Name or What Does Leukemia Inhibitory Factor Have to Do with the Pituitary Gland? Endocrinology, May 1, 1998; 139(5): 2199 - 2200. [Full Text] [PDF]

				M. Katahira, Y. Iwasaki, Y. Aoki, Y. Oiso, and H. Saito Cytokine Regulation of the Rat Proopiomelanocortin Gene Expression in AtT-20 Cells Endocrinology, May 1, 1998; 139(5): 2414 - 2422. [Abstract] [Full Text] [PDF]

				Y. Aoki, Y. Iwasaki, M. Katahira, Y. Oiso, and H. Saito Regulation of the Rat Proopiomelanocortin Gene Expression in AtT-20 Cells. I: Effects of the Common Secretagogues Endocrinology, May 1, 1997; 138(5): 1923 - 1929. [Abstract] [Full Text] [PDF]

				C. Bousquet, D. W. Ray, and S. Melmed A Common Pro-opiomelanocortin-binding Element Mediates Leukemia Inhibitory Factor and Corticotropin-releasing Hormone Transcriptional Synergy J. Biol. Chem., April 18, 1997; 272(16): 10551 - 10557. [Abstract] [Full Text] [PDF]

				D. Ray and S. Melmed Pituitary Cytokine and Growth Factor Expression and Action Endocr. Rev., April 1, 1997; 18(2): 206 - 228. [Abstract] [Full Text]

				Y. Sakai, N. Horiba, K. Sakai, F. Tozawa, A. Kuwayama, H. Demura, and T. Suda Corticotropin-Releasing Factor Up-Regulates Its Own Receptor Gene Expression in Corticotropic Adenoma Cells in Vitro J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1229 - 1234. [Abstract] [Full Text] [PDF]